ENDRA Life Sciences (NDRA) Research & Development (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Research & Development of $4278.0 for Q1 2026, down 93.8% year-over-year from $68991.0 in Q1 2025, and down 99.74% quarter-over-quarter from $1.7 million in Q4 2025.
ENDRA Life Sciences (NDRA) Research & Development (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Research & Development for 11 consecutive years, with $4278.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 93.8% year-over-year to $4278.0; the TTM figure through Mar 2026 stood at $2.2 million (up 30.37% YoY), while the FY2025 annual figure was $1.8 million, up 223.97% from the prior year.
- Research & Development slipped to $4278.0 in Q1 2026 per NDRA's latest filing, from $1.7 million in the prior quarter.
- Across five years, Research & Development topped out at $5.5 million in Q4 2022 and bottomed at $4278.0 in Q1 2026.
- Historically, Research & Development has averaged $1.3 million across 5 years, with a median of $1.0 million in 2024.
- Annual changes were most pronounced in 2024 — Research & Development sank 98.01% — and 2025, when it surged 1832.15%.
- ENDRA Life Sciences' Research & Development stood at $5.5 million in 2022, then slipped by 20.56% to $4.3 million in 2023, then tumbled by 98.01% to $86271.0 in 2024, then soared by 1832.15% to $1.7 million in 2025, then plunged by 99.74% to $4278.0 in 2026.
- Business Quant data shows NDRA's Research & Development at $4278.0 in Q1 2026, $1.7 million in Q4 2025, and $432113.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 364.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 412.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 228.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 126.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 171.28 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 252.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 52.99 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 233,665.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 233,665.00 |
| Mar 31, 2026 | 776,410.00 |
| Dec 31, 2025 | 508,137.00 |
| Sep 30, 2025 | 432,113.00 |
| Jun 30, 2025 | 381,061.00 |
| Mar 31, 2025 | 528,685.00 |
| Dec 31, 2024 | 637,957.00 |
| Sep 30, 2024 | 794,444.00 |
| Jun 30, 2024 | 716,366.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 579,350.00 |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.17 Mn |